Opioid-free anaesthesia versus opioid-based anaesthesia for laparoscopic radical prostatectomy: a prespecified analysis of a single-centre randomized controlled trial
PURPOSE: Opioid-free anaesthesia (OFA) is increasingly used to limit intraoperative opioids in oncological surgery, but evidence in radical prostatectomy is scarce. We compared OFA with a remifentanil-based technique in laparoscopic radical prostatectomy (LRP) on a uniform multimodal and regional analgesic background. METHODS: Adult men undergoing LRP were randomized to OFA (dexmedetomidine plus ketamine, no intraoperative opioids) or a remifentanil-based technique. Both groups received identical multimodal premedication, bilateral quadratus lumborum block, sevoflurane maintenance and identical oxycodone patient-controlled analgesia (PCA). The primary outcome was total oxycodone consumption over the first 24 postoperative hours. Pre-specified secondary outcomes included Numeric Rating Scale (NRS) pain scores, postoperative nausea and vomiting (PONV), serum creatinine change to day 1, and the demanded-to-delivered PCA bolus ratio. RESULTS: Fifty-seven patients were analysed (OFA n = 32; remifentanil n = 25). Total 24-h oxycodone consumption did not differ (location-shift estimate - 2.0 mg, 95% CI -8.0 to 6.0; p = 0.556), and neither NRS scores nor PONV differed significantly. The demanded-to-delivered PCA bolus ratio was lower with OFA (location-shift estimate - 0.20, 95% CI -0.267 to 0.000; p = 0.006), as was the early rise in serum creatinine (location-shift estimate - 7.7 µmol/L, 95% CI -13.9 to -1.1; p = 0.034). Intraoperative bradycardia and hypotension did not differ significantly. CONCLUSION: In LRP, no statistically significant difference in 24-hour oxycodone consumption or pain scores was detected between OFA and remifentanil-based anaesthesia. The trial was not designed or powered for equivalence or non-inferiority, and these findings therefore do not establish comparable efficacy. Differences in two pre-specified secondary outcomes (a lower demanded-to-delivered PCA ratio and a smaller early creatinine rise) are hypothesis-generating. Because recruitment was curtailed, findings require confirmation in adequately powered trials, ideally in robot-assisted prostatectomy. TRIAL REGISTRATION: ClinicalTrials.gov NCT06380244, registered 23 April 2024.
Authors
- Wojciech Szpunar (ORCID: https://orcid.org/0000-0002-2329-4844)
- Anna Kwinta (ORCID: https://orcid.org/0009-0006-2953-8068)
- Tomasz Drygalski
- Jan Szpor
- Tomasz Składzień (ORCID: https://orcid.org/0000-0002-5642-799X)
- Michał Cicio (ORCID: https://orcid.org/0000-0002-2653-2211)
- Katarzyna Maciejewska (ORCID: https://orcid.org/0009-0005-4041-6339)
- Maciejewski Pawel (ORCID: https://orcid.org/0009-0006-6898-1919)
- Tomasz Lonc (ORCID: https://orcid.org/0000-0001-8082-6547)
- Tomasz Klimczyk
- Aleksandra Żmuda (ORCID: https://orcid.org/0009-0005-3355-5242)
- Renata Bugielska
Institutions
- Jagiellonian University (PL)
Publication Details
- Journal
- World Journal of Urology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1007/s00345-026-06923-y
- Primary Topic
- Anesthesia and Pain Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00